Pharmacognosy Research logo
Submit
Pharmacognosy ResearchACADEMIC PUBLISHING
Article

Network Pharmacology Approach to Determine the Molecular Mechanism of Chitraka (Plumbago zeylanica L.) in the Treatment of Obesity

1, 1, 2

  1. 1Department of Samhita Siddhanta, KAHER’s Shri BMK Ayurveda Mahavidyalaya, Belagavi, Karnataka, INDIA.
  2. 2Department of Dravyaguna, KAHER’s Shri BMK Ayurveda Mahavidyalaya, Belagavi, Karnataka, INDIA.

CORRESPONDENCE

Dr. Praveen Nagappa Bhirdi

Department of Samhita Siddhanta, KAHER’s Shri BMK Ayurveda Mahavidyalaya, Belagavi, Karnataka, INDIA.

praveenbhirdi@kleayurworld.edu.in

Received: 16-05-2025; Accepted: 22-09-2025.

Volume 17, Issue 4 · pp. 1274-1280 · 2025 · DOI: 10.5530/pres.20252331

ABSTRACT

Background: The state of excessive bodily fat buildup is known as obesity (Sthoulya). Anti-obesity drugs in the market might cause adverse effects, for safer and more effective anti-obesity medications from plant-based sources becomes a top focus. In Ayurveda, Chitraka moola (Plumbago zeylanica L.) is a commonly used herb, because of its therapeutic effect. Network pharmacology is an area of drug discovery and development research by creating an opportunity for the methodical study of conventional treatments. This study highlights key phytochemicals, targets and signalling pathways of Chitraka for the treatment of obesity.Materials and Methods: This study assessed through biological databases, GeneCard, HPA databases, PPI Network Construction, KEGG pathway enrichment analysis, target-Compound-Pathway’ Network Construction and Molecular Docking Analysis.Results: Using the BindingDB and Uniprot databases, pinpointed 155 target genes with respect to these 28 active phytochemicals, Curated gene-disease data were extracted from the GeneCard and HPA databases based on the term obesity it was found that 26 out of the 28 drugs target exactly 137 disease targets linked to obesity, Using the String database, a PPI network was built. KEGG functional enrichment analysis to investigate the signalling pathways was carried out using SHINYGO database, Cytoscape was used to build the interaction relationship between 15 significantly enriched KEGG pathways, 137 intersecting targets and 26 core active ingredients, Molecular Docking visualises the binding pose with the highest docking score.Conclusion: This study emphasizes crucial mechanism, target and bioactive of Chitraka against obesity, indicating a strong pharmacological foundation for additional clinical research.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Hegade, P. B., Bhirdi, P. N., & Lingayat, A. (2025). Network Pharmacology Approach to Determine the Molecular Mechanism of Chitraka (Plumbago zeylanica L.) in the Treatment of Obesity. Pharmacognosy Research, 17(4), 1274-1280. https://doi.org/10.5530/pres.20252331

    Copyright and licence

    © 2025 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0